🇺🇸 FDA
Patent

US 10160961

Factor VII polypeptides that are modified and uses thereof

granted A61KA61K38/00A61K48/00

Quick answer

US patent 10160961 (Factor VII polypeptides that are modified and uses thereof) held by Catalyst Biosciences, Inc. expires Mon Dec 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Catalyst Biosciences, Inc.
Grant date
Tue Dec 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K38/00, A61K48/00, A61P, A61P7/04